Showing results (1-10 of 292) with videos related to
Sort By:
Pageof 30
Rheumatology Advances in Practice|February 1, 2021
Efficacy and safety of urate-lowering therapy in people with kidney impairment: a GCAN-initiated literature reviewHamish Farquhar, Ana B Vargas-Santos, Huai Leng Pisaniello, et al.Annals of Internal Medicine|June 6, 2022
In knee OA, PT vs. glucocorticoid injections had an incremental cost-effectiveness ratio of $35 527/QALY gainedAngelo L GaffoBest Practice & Research. Clinical Rheumatology|March 20, 2013
Thrombosis in vasculitisAngelo L GaffoRheumatic Diseases Clinics of North America|August 7, 2010
Diagnostic approach to ANCA-associated vasculitidesAngelo L GaffoArthritis Research & Therapy|April 29, 2021
Efficacy and safety of gout flare prophylaxis and therapy use in people with chronic kidney disease: a Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN)-initiated literature reviewHuai Leng Pisaniello, Mark C Fisher, Hamish Farquhar, et al.Current Opinion in Rheumatology|May 2, 2024
Investigating gout flares: beyond a definitionCharles Sutherland, Angelo L GaffoAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|December 30, 2011
Drug treatment of hyperuricemia to prevent cardiovascular outcomes: are we there yet?Angelo L Gaffo, Kenneth G SaagCurrent Rheumatology Reports|February 4, 2017
Rituximab in ANCA-Associated VasculitisRomina I Hassan, Angelo L GaffoTherapeutic Advances in Musculoskeletal Disease|August 6, 2016
Treatment of hyperuricemia in gout: current therapeutic options, latest developments and clinical implicationsSebastian E Sattui, Angelo L GaffoArthritis Research & Therapy|November 6, 2008
Serum urate, menopause, and postmenopausal hormone use: from eminence to evidence-based medicineAngelo L Gaffo, Kenneth G SaagPageof 30